(The Catholic Univ. of Korea, St. Vincent's Hospital, Korea)
Peter C. Dubsky
(Hirslanden Klinik St. Anna, Switzerland)
Speakers
Optimal Duration of Endocrine Therapy
Polly Suk Yee Cheung
(Hong Kong Sanatorium and Hospital, Hong Kong)
The Role of CDK4/6 Inhibitors in ER+/HER2- Early Breast Cancer
Tadahiko Shien
(Okayama Univ. Hospital, Japan)
ER+/HER2 Negative Premenopausal Breast Cancer- The Biomarker Way Forward
Peter C. Dubsky
(Hirslanden Klinik St. Anna, Switzerland)
Panel Discussion 1:
How to Manage Old-aged Breast Cancer Patients?15
Venue: RM 2(Vista 3)
Moderators
Jee Hyun Kim
(Seoul National Univ. Bundang Hospital, Korea)
Eun Sook Lee
(National Cancer Center, Korea)
Speakers
Screening and Assessment of Breast Cancer in Older Women
Lester Leong
(Singapore General Hospital, Singapore)
Systemic Therapy for Older Breast Cancer Patients
Jee Hyun Kim
(Seoul National Univ. Bundang Hospital, Korea)
Surgical Therapy for Older Breast Cancer Patient
Tristen Park
(Yale School of Medicine, U.S.A.)
Education Session 1:
Radiologist’s Perspectives on Neoadjuvant Systemic Therapy in Breast Cancer21
Venue: RM 3(Walker Hall 1)
Moderators
Hak Hee Kim
(ASAN Medical Center, Korea)
Boo-Kyung Han
(Samsung Medical Center, Korea)
Speakers
Causes of Over- and Underestimation of Tumor and Axillary LN After Neoadjuvant System Therapy
Beatriu Reig
(NYU Langone Health, U.S.A.)
Evaluation of Response to Neoadjuvant Systemic Therapy: Multiparametric Approach for Accurate Evaluation of Residual Tumor
Masako Kataoka
(Kyoto Univ., Japan)
How to Manage Residual Microcalcifications After Neoadjuvant Chemotherapy
Sung Hun Kim
(The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
Oral Presentation 1
51
Venue: RM 4(Walker Hall 2)
Speakers
BREAST CANCER IN ADOLESCENT & YOUNG ADULT (AYA) AGE GROUP HAS A SPECIFIC BIOLOGICAL FEATURE AND POOR OUTCOME COMPARED TO OTHER GENERATIONS
Masanori Oshi
(Yokohama City University Graduate School of Medicine, Japan)
CONSECUTIVE GAIN AND LOSS IN BODY WEIGHT AND WAIST CIRCUMFERENCE WITH RISK OF SUBSEQUENT BREAST CANCER IN KOREAN WOMEN
Thi Xuan Mai Tran
(Hanyang Univ. College of Medicine, Vietnam)
THE BURDEN OF BREAST CANCER IN YOGYAKARTA SPECIAL REGION, INDONESIA FROM 2008-2019: A TEMPORAL TREND ANALYSIS OF THE POPULATION-BASED CANCER REGISTRY DATA
Herindita Puspitaningtyas
(Faculty Of Medicine, Public Health And Nursing, Universitas Gadjah Mada,Yogyakarta, Indonesia)
AUGMENTING BREAST CANCER SCREENING EFFICIENCY BY MAXIMIZING DETECTION OF NORMAL MAMMOGRAMS USING AN ARTIFICIAL INTELLIGENCE ALGORITHM
Serene Si Ning Goh
(National Univ. of Singapore, Singapore)
THE EFFECT OF MAMMOGRAPHIC BREAST DENSITY ON DIAGNOSTIC OUTCOMES IN MEN
Hwan Lee
(Univ. of Pennsylvania, U.S.A.)
DRUG-RESISTANT EXTRACELLULAR VESICLES PREDICT TUMOR RESPONSE IN BREAST CANCER PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY
Jee Ye Kim
(Yonsei Univ. College of Medicine, Korea)
DEEP LEARNING-BASED QUANTITATIVE ESTIMATION OF LYMPHEDEMA-INDUCED FIBROSIS USING THREE-DIMENSIONAL COMPUTED TOMOGRAPHY IMAGES
Chang Ho Hwang
(Chungnam National Univ. College of Medicine, Korea)
PROGNOSTIC VALUE OF THE NGS-BASED MULTIGENE ASSAY TO PREDICT DISTANT METASTASIS IN HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE BREAST CANCER: ANALYSIS OF THE DEVELOPMENT COHORT WITH A FOLLOW-UP OF 95 MON
Eunhye Kang
(Seoul National Univ. Hospital, Korea)
FEASIBILITY AND HEALTH OUTCOMES OF HOME-BASED AEROBIC AND RESISTANCE TRAINING IN INDONESIAN BREAST CANCER PATIENTS
Yufi Kartika Astari
(Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Indonesia)
GBCC-SSO Joint Session:
Management of Hereditary Breast Cancer - Global Perspectives of Surgical Oncologists41
Venue: RM 5(Art Hall)
Moderators
Jeong Eon Lee
(Samsung Medical Center, Korea)
Tolga Ozmen
(Massachusetts General Hospital, U.S.A.)
Speakers
Management of Hereditary Breast Cancer in the U.S.
Tolga Ozmen
(Massachusetts General Hospital, U.S.A.)
Management of Hereditary Breast Cancer in Europe
Isabel T. Rubio
(Clinica Universidad de Navarra, Spain)
Management of Hereditary Breast Cancer in Asia
Sung-Won Kim
(Daerim St. Mary's Hospital, Korea)
10:30-11:45
Symposium 2:
HER2-Low as a Targetable Subset of Breast Cancer7
Venue: RM 1(Vista 1+2)
Moderators
Kyong Hwa Park
(Korea Univ. Anam Hospital, Korea)
Naoto Ueno
(Univ. of Hawai'i Cancer Center, U.S.A.)
Speakers
Is HER2-Low Breast Cancer an Independent/Distinctive Subtype?
Naoto Ueno
(Univ. of Hawai'i Cancer Center, U.S.A.)
How to Identify HER2-Low Breast Cancer
Hee Jin Lee
(ASAN Medical Center, Korea)
Targeting HER2-Low and the Treatment Sequence
Wei-Pang Chung
(National Cheng Kung Univ. Hospital, Taiwan)
Panel Discussion 2:
Various Considerations in Premenopausal Breast Cancer Patients16
Venue: RM 2(Vista 3)
Moderators
Min Sung Chung
(Hanyang Univ. Seoul Hospital, Korea)
Eric Schneider
(Yale School of Medicine, U.S.A.)
Speakers
The Optimal Endocrine Combination with OFS
Hee Jeong Kim
(ASAN Medical Center, Korea)
Targeted Therapy for High-risk Patients and gBRCA Mutation Patients
Hee Kyung Ahn
(Gachon Univ. Gil Medical Center, Korea)
Prophylactic Mastectomy
Eric Schneider
(Yale School of Medicine, U.S.A.)
Education Session 2:
Genomic Assays and Treatment Decision22
Venue: RM 3(Walker Hall 1)
Moderators
Hyun Jo Youn
(Jeonbuk National Univ. Hospital, Korea)
Kevin Kalinsky
(Winship Cancer Institute of Emory Univ., U.S.A.)
Speakers
Optimal Decisions on Adjuvant Endocrine and Chemotherapy Using Multigene Assays
Chi-Cheng Huang
(Taipei Veterans General Hospital, Taiwan)
Clinical Parameters as Alternatives to Genomic Assays
Jong Won Lee
(ASAN Medical Center, Korea)
Interpretation of Genomic Assays in Premenopausal Women
Kevin Kalinsky
(Winship Cancer Institute of Emory Univ., U.S.A.)
Oral Presentation 2
52
Venue: RM 4(Walker Hall 2)
Speakers
GENOMIC CHARACTERIZATION OF HORMONE RECEPTOR-POSITIVE ADVANCED BREAST CANCER WITH HIGH TUMOR MUTATIONAL BURDEN: FRESH-FROZEN TISSUE GENOMIC ANALYSIS FROM MUTATION-1 STUDY (KCSG BR17-04)
Min Hwan Kim
(Yonsei Univ. College of Medicine, Korea)
BROWN ADIPOCYTE FACILITATES BREAST CANCER INVASIVENESS VIA CELL FUSION
Shihang Hu
(The Univ. of Hong Kong, Hong Kong)
COMBINATION OF LOCAL RADIOTHERAPY AND ANTI-GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) THERAPY AUGMENTS PD-L1 BLOCKADE-MEDIATED ANTI-TUMOR EFFECTS IN MURINE BREAST CANCER MODEL
Jun Yeong Song
(Seoul National Univ. Hospital, Korea)
COMPARISON OF TRANSCRIPTOME PROFILES BETWEEN HER2-LOW AND HER2-ZERO BREAST CANCER
Po-Hsiang Huang
(National Taiwan University Hospital, Taiwan)
GERMLINE MUTATIONS RELATED TO COMPLETE REMISSION AFTER NEOADJUVANT THERAPY DETECTED BY MULTIGENE PANELS IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER
Jee Hyun Ahn
(Yonsei Univ. College of Medicine, Korea)
EXPLORATION OF MELK AS A DOWNSTREAM OF DEL-1 & DRUGGABLE TARGET IN TNBC
In Hee Lee
(Kyungpook National Univ. Chilgok Hospital, Korea)
SYMPTOM CLUSTER AND PREDICTORS OF GENERAL CHEMOTHERAPY TOXICITY IN PATIENTS WITH BREAST CANCER: EXPLORATORY FACTOR ANALYSIS (EFA) AND A CHI-SQUARE AUTOMATIC INTERACTION DETECTOR (CHAID) DECISION TREE
Juan Adrian Wiranata
(Master Of Clinical Epidemiology Postgraduate Program, Indonesia)
B-CELL MEDIATED IMMUNITY PREDICTS SURVIVAL OF ER-POSITIVE BREAST CANCER
Byung-Hee Kang
(Seoul National Univ. Bundang Hospital, Korea)
IMPROVEMENT OF DIAGNOSTIC ACCURACY OF BREAST CANCER USING MULTI-PROTEIN SIGNATURE MARKERS THROUGH MACHINE LEARNING
Yumi Kim
(CHA Gangnam Medical Center, Korea)
GBCC-JBCS Joint Session:
Holistic Management for Breast Cancer Patients in Pandemic Era42
Venue: RM 5(Art Hall)
Moderators
Sung Yong Kim
(Soonchunhyang Univ. Hospital Cheonan, Korea)
Hiroko Bando Tamura
(Univ. of Tsukuba, Japan)
Speakers
Present and Future Perspectives in Korea
So-Youn Jung
(National Cancer Center, Korea)
Present and Future Perspectives in Japan
Akihiko Shimomura
(National Center for Global Health and Medicine, Japan)
Panelist
Discussion
Beom Seok Kwak
(Dongguk Univ. Ilsan Hospital, Korea)
In Hae Park
(Korea Univ. Guro Hospital, Korea)
Fumikata Hara
(Cancer Institute Hospital of JFCR, Japan)
12:00-12:45
Plenary Lecture 1
1
Venue: RM 1(Vista 1+2)
Moderators
Seock-Ah Im
(Seoul National Univ. Hospital, Korea)
Speakers
A Revolution in the Making: How Antibody-Drug Conjugates are Transforming Breast Cancer Treatment
Ian Krop
(Yale School of Medicine, U.S.A.)
13:00-13:45
Satellite Symposium 1:
MSD Korea45
Venue: RM 1(Vista 1+2)
Moderators
TBD
(, )
Speakers
Pembrolizumab for More TOMORROWs in TNBC
Yen-Shen Lu
(National Taiwan Univ. Hospital, Taiwan)
14:00-14:45
Plenary Lecture 2
2
Venue: RM 1(Vista 1+2)
Moderators
Joohyuk Sohn
(Yonsei Cancer Center, Korea)
Speakers
Fertility Issues in Young Breast Cancer Patients
Sibylle Loibl
(GBG Forschungs GmbH, Germany)
15:00-16:15
Panel Discussion 3:
Optimal Surgical Treatment After Neoadjuvant Chemotherapy17
Venue: RM 2(Vista 3)
Moderators
Jun Won Min
(Dankook Univ. Hospital, Korea)
Christoph Tausch
(Breast-Center Zurich, Switzerland)
Speakers
Avoiding Breast Surgery in Patients with Radiologic Complete Response
Christoph Tausch
(Breast-Center Zurich, Switzerland)
De-escalation of Sentinel Lymph Node Biopsy in Patients with Radiologic Complete Response
Shih-Che Shen
(Chang Gung Memorial Hospital, Taiwan)
De-escalation of Radiotherapy in Patients Achieved Pathologically Complete Response
Yeon-Joo Kim
(National Cancer Center, Korea)
Symposium 3:
Beyond CDK4/6 Inhibitor: New Target and New Drugs8
Venue: RM 3(Walker Hall 1)
Moderators
Jin-Hee Ahn
(ASAN Medical Center, Korea)
Nadia Harbeck
(LMU Univ. Hospital, Germany)
Speakers
Novel Oral SERD and its Implication in Clinical Practice
Yen-Shen Lu
(National Taiwan Univ. Hospital, Taiwan)
Treatment Strategy After Progression on CDK4/6 Inhibitor
Nadia Harbeck
(LMU Univ. Hospital, Germany)
New Targets Beyond CDK4/6 Inhibitor: Development in Progress
Yong Wha Moon
(CHA Bundang Medical Center, Korea)
Oral Presentation 3
53
Venue: RM 4(Walker Hall 2)
Speakers
IMPACT OF RESIDUAL MICROCALCIFCATIONS ON PROGNOSIS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
Eun Young Kim
(Kangbuk Samsung Hospital, Korea)
IS AGE AN INDEPENDENT FACTOR OF LATE RECURRENCE AMONG YOUNG BREAST CANCER PATIENTS WITH ESTROGEN RECEPTOR POSITIVE/HER2 NEGATIVE?
Dong Seung Shin
(Samsung Medical Center, Korea)
STROMAL TUMOR INFILTRATING LYMPHOCYTES (TIL) AS A POTENTIAL PROGNOSTIC BIOMARKER FOR RECURRENCE IN LOCALLY ADVANCED BREAST CANCER (LABC) PATIENTS
Dannu Novriandhika
(Medical Faculty Airlangga University, Dr Soetomo General Hospital Surabaya, Indonesia)
DEVELOPMENT OF BREAST CANCER RISK PREDICTION MODEL INCORPORATING POLYGENIC RISK SCORE AND NONGENETIC RISK FACTORS IN KOREAN WOMEN
Jihye Choi
(National Medical Center, Korea)
LONG-TERM PROGNOSTIC VALUE OF THE GENESWELL BCT SCORE IN ASIAN WOMEN WITH HORMONE RECEPTOR-POSITIVE/HER2-NEGATIVE EARLY BREAST CANCER
Youngwon Lee
(ASAN Medical Center, Korea)
ESTABLISHING THE CORRELATION OF AN 8-GENE SET OF IMMUNE-RESPONSE GENE EXPRESSION PROFILING WITH PATHOLOGICAL COMPLETE RESPONSE NEOADJUVANT CHEMOTHERAPY IN PRIMARY BREAST CANCER PATIENTS
Chun-Yu Liu
(Taipei Veterans General Hospital, Taiwan)
THE EFFECT OF PROGESTERONE RECEPTOR EXPRESSION LEVEL TO PREDICT PROGNOSIS OF ESTROGEN RECEPTOR POSITIVE/ HER2 NEGATIVE YOUNG BREAST CANCER: A SINGLE-CENTER PROSPECTIVE COHORT STUDY.
Youngji Kwak
(Samsung Medical Center, Korea)
ELUCIDATING THE MUTATIONAL LANDSCAPE OF PI3K PATHWAY AMONG INDIAN BREAST CANCER CASES.
Rahul Kumar
(All India Institute of Medical Sciences, New Delhi, India)
GBCC-TBCS Joint Session:
Making Evidences Together43
Venue: RM 5(Art Hall)
Moderators
Hyun Jo Youn
(Jeonbuk National Univ. Hospital, Korea)
Chiun-Sheng Huang
(National Taiwan Univ. Hospital, Taiwan)
Speakers
Breast Cancer Registry from the Korean Breast Cancer Society
Jaihong Han
(National Cancer Center, Korea)
Nationwide Taiwanese Breast Cancer Study
Ching-Hung Lin
(National Taiwan Univ. Hospital, Taiwan)
Korean Breast Cancer Study Using National Insurance Big Data
Sungmin Park
(Chungbuk National Univ. Hospital, Korea)
Panelist
Discussion
Soo Youn Bae
(The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
Zisun Kim
(Soonchunhyang Univ. Hospital Bucheon, Korea)
Shin-Cheh Chen
(Chang Gung Memorial Hospital, Taiwan)
Fang-Ming Chen
(Kaohsiung Municipal Ta-Tung Hospital, Taiwan)
16:30-17:45
Education Session 3:
Special Issues in Young Women with Breast Cancer Treated with Radiotherapy23
Venue: RM 2(Vista 3)
Moderators
Yong Bae Kim
(Yonsei Cancer Center, Korea)
Haeyoung Kim
(Samsung Medical Center, Korea)
Speakers
Breast Radiotherapy During Pregnancy
Stefanie Corradini
(Univ. Hospital, LMU Munich, Germany)
Risk of Contralateral Breast Cancer After Breast Radiotherapy in Young Women
Seung Won Seol
(Univ. of Pennsylvania, U.S.A.)
Heart Disease After Breast Radiotherapy in Young Women
Ji Hyeon Joo
(Pusan National Univ. Yangsan Hospital, Korea)
Symposium 4:
Tailored Surgery in Early-stage Breast Cancer9
Venue: RM 3(Walker Hall 1)
Moderators
Yongsik Jung
(Ajou Univ. Hospital, Korea)
Caroline Drukker
(Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Netherlands)
Speakers
Individualized Surgical Extent and Lumpectomy Margin in Early-stage Breast Cancer: Does Tumor Histology and Subtype Matter?
Naoki Hayashi
(Showa Univ. School of Medicine, Japan)
The Role of Axillary Surgery for DCIS and Early-stage Breast Cancer
Wonshik Han
(Seoul National Univ. Hospital, Korea)
Pre-operative Genomic Assay for Breast Surgery Guidance in HR+/HER2- Breast Cancer
Caroline Drukker
(Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Netherlands)
Oral Presentation 4
54
Venue: RM 4(Walker Hall 2)
Moderators
Okhee Woo
(Korea Univ. Guro Hospital, Korea)
Hyung Seok Park
(Yonsei Univ. College of Medicine, Korea)
Speakers
NATIONAL PATTERNS OF HOSPITAL ADMISSION VS HOME RECOVERY FOLLOWING MASTECTOMY FOR BREAST CANCER
Leah Kim
(Yale University School of Medicine, U.S.A.)
IMPACT OF DISTANCE BETWEEN TUMOR AND NIPPLE ON SURVIVAL OUTCOMES IN BREAST CANCER
Jong-Ho Cheun
(SMG-SNU Boramae Medical Center, Korea)
THE IMPACT OF CAVITARY MARGIN SHAVING OF BREAST CONSERVING SURGERY: THE ONCOLOGICAL OUTCOME
Dabin Kim
(Soonchunhyang Univ. Hospital Bucheon, Korea)
FUNCTIONALITY BETWEEN BREAST CONSERVATION SURGERY VS MASTECTOMY: SHORT TERM OUTCOME FROM A SINGLE INSTITUTION
Lorraine Ma
(Pamela Youde Nethersole Eastern Hospital, Hong Kong)
POST-OPERATIVE OUTCOMES OF ROBOT-ASSISTED NIPPLE-SPARING MASTECTOMY WITH IMMEDIATE BREAST RECONSTRUCTION REGARDING TO ROBOT SURGICAL SYSTEMS
Jieon Go
(Severance Hospital, Korea)
COMPARISON OF LONG-TERM ONCOLOGICAL OUTCOMES OF CENTRAL LUMPECTOMY AND CONVENTIONAL BREAST-CONSERVING SURGERY FOR INVASIVE BREAST CANCER
Jijung Jung
(Seoul National Univ., Korea)
RISK FACTOR OF SKIN AND NIPPLE-AREOLAR COMPLICATION AND ONCOLOGIC SAFETY IN DIFFERENT APPROACH NIPPLE SPARING MASTECTOMY: A LONG-TERM FOLLOW-UP IN A SINGLE MEDICAL CENTER
Ruoh Yun Gau
(Chang Gung Memorial Hospital, Taiwan)
LONG-TERM ONCOLOGICAL OUTCOMES OF ONCOPLASTIC BREAST-CONSERVING SURGERY AFTER A 10-YEAR FOLLOW-UP: A SINGLE CENTER EXPERIENCE AND SYSTEMATIC LITERATURE REVIEW
Byeongju Kang
(Kyungpook National Univ. Chilgok Hospital, Korea)
OCCULT LYMPH NODE METASTASES IN CLINICALLY NODE-NEGATIVE (CN0) BREAST CANCER PATIENTS REFERRED FOR NEOADJUVANT THERAPY (NAT).
Si Ying Tan
(Singapore General Hospital, Singapore)
GBCC-CACA Joint Session:
Programs for Breast Cancer Screening and Prevention44
Venue: RM 5(Art Hall)
Moderators
Il Yong Chung
(ASAN Medical Center, Korea)
Peng Yuan
(Chinese Academy of Medical Sciences, Cancer Hospital, China)
Speakers
KBCS Guidelines of Screening and Current Status
Young-Joon Kang
(The Catholic Univ. of Korea, Incheon St. Mary's Hospital, Korea)
CACA Guidelines of Screening and Current Status
Yongsheng Wang
(Shandong Cancer Hospital & Institute, China)
Korean Recommendations for Prevention and Risk Managements
Yoo Seok Kim
(Chosun Univ. Hospital, Korea)
Chinese Recommendations for Prevention and Risk Managements
Junjie Li
(Fudan Univ. Shanghai Cancer Center, China)
Panelist
Discussion
Kyung-Hun Lee
(Seoul National Univ. Hospital, Korea)
Sung Eun Song
(Korea Univ. Anam Hospital, Korea)
Yanxia Shi
(Sun Yat-Sen Univ. Cancer Center, China)
Yu Ren
(The First Affiliated Hospital of Xi'an Jiaotong Univ., China)
KEEP ME UPDATED
Sign up for GBCC Newsletter
Global Breast Cancer Conference Secretariat
Partner I INTERCOM Convention Services, Inc. (Core PCO)
6Fl., squareME Bldg., 225 Bongeunsa-ro, Gangnam-gu, Seoul 06109, Korea